toleravat

Tolervat is a medication used to treat symptoms of attention deficit hyperactivity disorder (ADHD). It was approved for medical use in the United States in 2003 after being developed by the pharmaceutical company Novartis.

The active ingredient in tolervat is a central nervous system stimulant, which helps to regulate dopamine and norepinephrine levels in the brain. These neurotransmitters play a key role in attention and impulse control. By increasing their availability, tolervat helps to alleviate symptoms of ADHD such as inattention, hyperactivity, and impulsivity.

Tolervat is typically prescribed in conjunction with a low-fat diet to minimize the risk of cardiovascular side effects. It is available in immediate-release and extended-release formulations, with the extended-release formulation allowing for once-daily dosing. The immediate-release formulation is often used for moderate to severe ADHD symptoms.

Common side effects of tolervat include headache, dyspepsia, and insomnia. In rare cases, the medication can cause more serious side effects such as anaphylaxis, Stevens-Johnson syndrome, and Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). People taking tolervat are also at risk for dependence and overdose, particularly when taken in excess.

Researchers have also studied the potential use of tolervat in treating conditions such as sleep disorders, certain types of depression, and substance abuse. However, more research is needed to confirm its effectiveness and safety in these areas.

Regulatory agencies such as the US FDA have approved tolervat for use by patients of all ages, including children, adolescents, and adults. However, as with any medication, patients should only take tolervat under the guidance of a qualified healthcare professional.